BLUMENTHAL & MERKLEY RAISE CONCERNS ABOUT FDA PILOT PROGRAM THAT WOULD EXPEDITE REVIEW OF NICOTINE POUCHES, UNDERCUT SCIENTIFIC STANDARDS
“As public health experts have emphasized, any efforts to speed up FDA review must not come at the expense of protecting youth from highly addictive nicotine products.” [WASHINGTON, DC] – Today, U.S. Senators Richard Blumenthal (D-CT) and Jeff Merkley (D-OR) wrote to Food and Drug Administration (FDA) Commissioner Martin Makary, raising concerns